Millennial Sisters Develop Potential First Longevity Drug
TL;DR Summary
Two young sisters, Carina and Serena Kern-Libera, have founded LinkGevity to develop a pioneering drug targeting necrosis, a key process in ageing, with promising lab results and plans for human trials, aiming to extend healthy lifespan and address age-related diseases.
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
13 min
vs 13 min read
Condensed
98%
2,582 → 40 words
Want the full story? Read the original article
Read on The Times